Syneron Medical Ltd (ELOS) Reports In-Line Q2 EPS

Syneron Medical Ltd (NASDAQ: ELOS) reported Q2 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $64.6 million versus the consensus estimate of $63.52 million.

For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• SPS Commerce (SPSC) Tops Q1 EPS by 12c
• Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance